1+ day, 4+ hour ago   (149+ words) Gilead Research Scholars Program in Solid Tumors 2026 Oncodaily Gilead Research Scholars Program in Solid Tumors 2026 The Gilead Research Scholars Program in Solid Tumors 2026 supports early-career investigators conducting independent basic or clinical research addressing unmet needs in breast, endometrial, ovarian, or…...

1+ day, 17+ hour ago   (194+ words) OncoDaily is a specialized news and information platform that provides daily updates on oncology research, treatments, clinical trials, and advancements in cancer care. It serves healthcare professionals, researchers, and patients by delivering timely and accurate insights into the latest developments…...

3+ day, 16+ hour ago   (253+ words) JCO Journals shared on LinkedIn: “Could serial ctDNA monitoring provide an earlier window into treatment response in early-stage breast cancer? A prospective pilot study evaluated tumor-informed circulating tumor DNA (ctDNA) before, during, and after neoadjuvant therapy in patients with stage…...

3+ day, 23+ hour ago   (254+ words) David Spetzler, President of Caris Life Sciences, shared on LinkedIn: “Nearly half the patients in our new pancreatic study received a different first-line treatment than the one our model identified as more likely to benefit them. The research, recently published…...

3+ day, 23+ hour ago   (116+ words) BOT+BAL: Three-Year Overall Survival Data in Recurrent Ovarian Cancer - Agenus / Agenus, Balstilimab, BOTBAL, botensilimab, C-800-01, cancer, OncoDaily,, Agenus, Balstilimab, BOTBAL, botensilimab, C-800-01, cancer, OncoDaily, Oncology, Ovarian Cancer, overall survival, Phase 1b, Phase 1b Clinical Trial, Recurrent ovarian cancer Agenus, shared on LinkedIn: “Agenus…...

4+ day, 5+ hour ago   (208+ words) Liang Cheng, Director of Anatomic and Molecular Pathology at Brown Pathology and Laboratory Medicine, shared on LinkedIn: “In case you missed my earlier post, here’s the companion (twin!) comprehensive review on prostatic neuroendocrine tumors, published in Endocrine Pathology, written by…...

1+ week, 1+ hour ago   (156+ words) Eleonora Dondossola, Assistant Professor in the Department of Genitourinary Medical Oncology – Research, Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center, shared on LinkedIn: “Big celebrations for my first R01! This funding will allow us to investigate…...

1+ week, 4+ hour ago   (172+ words) Humam Kadara: Grateful to Receive a Breakthroughs Discovery Program Award at UT MD Anderson / Aria Vaishnavi, cancer, Ferdinandos Skoulidis, Humam Kadara, Jay, Aria Vaishnavi, cancer, Ferdinandos Skoulidis, Humam Kadara, Jay Zhang, Jia Wu, Johannes Fahrmann, Linghua Wang, Luisa Solis, Lung…...

1+ week, 1+ day ago   (91+ words) World Ovarian Cancer Coalition shared on LinkedIn: “We’re strengthening our Board with three new voices. Together, they bring expertise across communications and governance, law and policy, and lived patient experience – strengthening our leadership as we work towards a world where…...

1+ week, 1+ day ago   (188+ words) Alberto Puccini, Medical Oncologist at IRCCS Humanitas Research Hospital, shared on LinkedIn. “Our paper is out in Nature Reviews Gastroenterology and Hepatology! I am incredibly proud of Michela Bartolini, one of my first fellows, who, through a wonderful collaboration with…...